Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05565443 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05565443 · ClinicalTrials.gov record · last posted 2026-01-23

MR-guided Focused Ultrasound Plus GCase

StatusRecruiting
PhaseNot applicable
SponsorInSightec
Started2022-11-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this study is to establish safety and feasibility of intracerebral delivery of GCase via MRgFUS. This technique may offer potential benefits given the exposure of the putamen to GCase in animal models has been shown to be efficacious in improving Parkinson's disease pathology and phenotype.

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2022-09-29; most recent amendment 2026-01-22. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-09-01
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05565443
Lead Sponsor InSightec
Conditions Parkinsons Disease
Enrollment 14 participants
Start Date 2022-11-30
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-23